Original Research

Published on 02 Aug 2022

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ke Su
Lu Guo
Kun He
Mingyue Rao
Jianwen Zhang
Xiaoli Yang
Weihong Huang
Tao Gu
Ke Xu
Yanlin Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.873830

2,984 views
30 citations

Original Research

Published on 01 Aug 2022

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Weiwei Li
Yinxuan Pei
Zixiang Wang
Jinlong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.930868

3,365 views
13 citations

Original Research

Published on 01 Aug 2022

Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Huijie Gao
Zhaobin He
Chao Gao
Naiqing Liu
Zhaoyang Zhang
Weibo Niu
Jun Niu
Cheng Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.936507

2,475 views
6 citations

Original Research

Published on 29 Jul 2022

Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ying Liu
Song Liu
Guang Sheng Zhao
Xiang Li
Fei Gao
Zhi Zhong Ren
Jie Bian
Jian Lin Wu
Yue Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.889312

1,534 views
2 citations

Original Research

Published on 29 Jul 2022

Association of preoperative albumin–bilirubin with surgical textbook outcomes following laparoscopic hepatectomy for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fei-Qi Xu
Tai-Wei Ye
Dong-Dong Wang
Ya-Ming Xie
Kang-Jun Zhang
Jian Cheng
Zun-Qiang Xiao
Si-Yu Liu
Kai Jiang
Wei-Feng Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.964614

1,580 views
6 citations

Original Research

Published on 29 Jul 2022

Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Feifei Shen
Chuan Liu
Weiguo Zhang
Sijia He
Fan Wang
Jingjue Wang
Qi Li
Fei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.964115

1,774 views
4 citations

Original Research

Published on 29 Jul 2022

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zuowei Wu
Pengcheng Zhao
Zihe Wang
Xing Huang
Chao Wu
Mao Li
Li Wang
Bole Tian

Frontiers in Oncology

doi 10.3389/fonc.2022.966256

2,194 views
6 citations

Original Research

Published on 29 Jul 2022

Comparison of clinicopathologic characteristics and survival outcomes between invasive IPMN and invasive MCN: A population-based analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhen Yang
Guangjun Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.899761

3,444 views
5 citations

Original Research

Published on 28 Jul 2022

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zuqin Rao
Heng Li
Wenchao Yao
Qiang Wang
Biao Ma
Dongbo Xue
Xianzhi Meng

Frontiers in Oncology

doi 10.3389/fonc.2022.927468

2,270 views
1 citation

Original Research

Published on 25 Jul 2022

A Mouse Model of Damp-Heat Syndrome in Traditional Chinese Medicine and Its Impact on Pancreatic Tumor Growth

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Juying Jiao
Chien-shan Cheng
Panling Xu
Peiwen Yang
Linjie Ruan
Zhen Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.947238

3,430 views
1 citation

Original Research

Published on 25 Jul 2022

Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yifan Han
Jianxiang Liu
Jiali Pan
Hongyu Chen
Ning Tan
Qian Kang
Yuqing Yang
Xiaoyuan Xu
Wengang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.903355

1,379 views
1 citation

Original Research

Published on 25 Jul 2022

Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yiming Li
Cong Xu
Bo Sun
Fangjing Zhong
Momo Cao
Lianyue Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.913498

2,503 views
2 citations

Case Report

Published on 25 Jul 2022

Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Taotao Zhou
Robert Mahn
Christian Möhring
Farsaneh Sadeghlar
Carsten Meyer
Marieta Toma
Barbara Kreppel
Markus Essler
Tim Glowka
Hanno Matthaei

Frontiers in Oncology

doi 10.3389/fonc.2022.933943

3,417 views
8 citations

Original Research

Published on 22 Jul 2022

Immune-Related Biomarkers Improve Performance of Risk Prediction Models for Survival in Patients With Hepatocellular Carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Haifeng Wan
Shan Lu
Lin Xu
Kefei Yuan
Yang Xiao
Kunlin Xie
Hong Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.925362

2,300 views
1 citation

Original Research

Published on 22 Jul 2022

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Zhang
Shukui Qin
Jiaojiao Chao
Yan Luo
Yandi Sun
Jianxin Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.885139

2,571 views
3 citations

Technology and Code

Published on 22 Jul 2022

Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xinye Qian
Wang Hu
Lu Gao
Jingyi Xu
Bo Wang
Jiyong Song
Shizhong Yang
Qian Lu
Lin Zhang
Jun Yan

Frontiers in Oncology

doi 10.3389/fonc.2022.966626

2,105 views
7 citations

Navigation group

Articles

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Exosome-transmitted miR-3124-5p promotes cholangiocarcinoma development via targeting GDF11

Early changes in peripheral blood cytokine levels after the treatment of metastatic hepatic carcinoma with CalliSpheres microspheres drug-eluting beads transcatheter arterial chemoembolization

Association of preoperative albumin–bilirubin with surgical textbook outcomes following laparoscopic hepatectomy for hepatocellular carcinoma

Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer

Adjusting CA19-9 values with clinical stage and bilirubin to better predict survival of resectable pancreatic cancer patients: 5-year-follow-up of a single center

Comparison of clinicopathologic characteristics and survival outcomes between invasive IPMN and invasive MCN: A population-based analysis

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC

A Mouse Model of Damp-Heat Syndrome in Traditional Chinese Medicine and Its Impact on Pancreatic Tumor Growth

Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy

Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA

Case Report: Sustained complete remission on combination therapy with olaparib and pembrolizumab in BRCA2-mutated and PD-L1-positive metastatic cholangiocarcinoma after platinum derivate

Immune-Related Biomarkers Improve Performance of Risk Prediction Models for Survival in Patients With Hepatocellular Carcinoma

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer

Trans-arterial positive ICG staining-guided laparoscopic liver watershed resection for hepatocellular carcinoma